| scholarly article | Q13442814 |
| P50 | author | Ninna Aggerholm-Pedersen | Q41699364 |
| Brita S. Sørensen | Q41699366 | ||
| Jan Alsner | Q41699368 | ||
| Akmal Safwat | Q42028656 | ||
| P2093 | author name string | Jens Overgaard | |
| Katja Maretty-Kongstad | |||
| Steen Baerentzen | |||
| Marianne Nordsmark | |||
| Ole Steen Nielsen | |||
| Kasper Toustrup | |||
| P2860 | cites work | Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck | Q62032270 |
| Correlations between 31P-NMR spectroscopy and tissue O2 tension measurements in a murine fibrosarcoma | Q69399248 | ||
| Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma | Q71102409 | ||
| The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas | Q71216564 | ||
| Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix | Q71545581 | ||
| The importance of determining necrotic fraction when studying the effect of tumour volume on tissue oxygenation | Q72308493 | ||
| Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche | Q24606366 | ||
| Regulation of cancer cell metabolism | Q28303890 | ||
| Genesis: cluster analysis of microarray data | Q29619630 | ||
| Hypoxia in human intraperitoneal and extremity sarcomas | Q31926058 | ||
| Prognostic factors for local recurrence and mortality in adult soft tissue sarcoma of the extremities and trunk wall: a cohort study of 922 consecutive patients | Q33775027 | ||
| Hypoxia and the extracellular matrix: drivers of tumour metastasis | Q34820282 | ||
| Tumor mechanics and metabolic dysfunction | Q35117423 | ||
| Prognostic significance of tumor oxygenation in humans. | Q35136222 | ||
| Expression of hypoxic markers and their prognostic significance in soft tissue sarcoma | Q35167655 | ||
| Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations | Q36622927 | ||
| Population-based Aarhus Sarcoma Registry: validity, completeness of registration, and incidence of bone and soft tissue sarcomas in western Denmark | Q36848219 | ||
| Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis. | Q37294778 | ||
| Imaging hypoxia to improve radiotherapy outcome | Q38059626 | ||
| Relevance of hypoxia in radiation oncology: pathophysiology, tumor biology and implications for treatment. | Q38138795 | ||
| Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium | Q38263008 | ||
| Common responses of tumors and wounds to hypoxia. | Q38393439 | ||
| Identification of accurate reference genes for RT-qPCR analysis of formalin-fixed paraffin-embedded tissue from primary non-small cell lung cancers and brain and lymph node metastases | Q38396908 | ||
| RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods | Q38420708 | ||
| Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α. | Q38496656 | ||
| Gene Expression Signatures as Biomarkers of Tumour Hypoxia | Q38568536 | ||
| Hypoxia-activated prodrugs: paths forward in the era of personalised medicine. | Q38806173 | ||
| The usability of a 15-gene hypoxia classifier as a universal hypoxia profile in various cancer cell types. | Q38853603 | ||
| Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer | Q39489446 | ||
| Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro | Q39709316 | ||
| Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity | Q39859811 | ||
| Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis | Q40948678 | ||
| The importance of reference gene analysis of formalin-fixed, paraffin-embedded samples from sarcoma patients - an often underestimated problem | Q41699302 | ||
| Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours | Q44514473 | ||
| Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcoma. | Q45917673 | ||
| The effect of tumor size on necrosis and polarographically measured pO2. | Q47317736 | ||
| Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study | Q47746681 | ||
| Validation of a 15-gene hypoxia classifier in head and neck cancer for prospective use in clinical trials. | Q48810292 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International | Q42553662 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1096-1104 | |
| P577 | publication date | 2016-10-04 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | A prognostic profile of hypoxia-induced genes for localised high-grade soft tissue sarcoma | |
| P478 | volume | 115 |
| Q55236680 | Combined Use of the Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as a Prognostic Predictor in Patients with Operable Soft Tissue Sarcoma. |
| Q47318963 | The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma. |
| Q50105567 | Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts. |
Search more.